Published in Appl Environ Microbiol on October 01, 1983
Survival of enteric viruses on environmental fomites. Appl Environ Microbiol (1994) 2.41
Significance of fomites in the spread of respiratory and enteric viral disease. Appl Environ Microbiol (2007) 2.05
Institutional outbreaks of rotavirus diarrhoea: potential role of fomites and environmental surfaces as vehicles for virus transmission. J Hyg (Lond) (1986) 1.57
Chemical disinfection of human rotavirus-contaminated inanimate surfaces. J Hyg (Lond) (1986) 1.32
Rotavirus survival on human hands and transfer of infectious virus to animate and nonporous inanimate surfaces. J Clin Microbiol (1988) 1.31
In vivo protocol for testing efficacy of hand-washing agents against viruses and bacteria: experiments with rotavirus and Escherichia coli. Appl Environ Microbiol (1989) 1.24
Survival of hepatitis A virus on human hands and its transfer on contact with animate and inanimate surfaces. J Clin Microbiol (1992) 1.21
Longitudinal study of occurrence of diarrheal disease in day care centers. Am J Public Health (1984) 1.17
Asymptomatic rotavirus infections in day care centers. J Clin Microbiol (1985) 1.01
Transfer efficiency of bacteria and viruses from porous and nonporous fomites to fingers under different relative humidity conditions. Appl Environ Microbiol (2013) 0.97
Choice of reference assay for the detection of rotavirus in fecal specimens: electron microscopy versus enzyme immunoassay. J Clin Microbiol (1990) 0.96
The day care center diarrhea dilemma. Am J Public Health (1986) 0.92
Prevention of surface-to-human transmission of rotaviruses by treatment with disinfectant spray. J Clin Microbiol (1991) 0.91
Comparison of surface sampling methods for virus recovery from fomites. Appl Environ Microbiol (2011) 0.90
Infectious diseases in day-care centres: minimizing the risk. CMAJ (1987) 0.84
Infection control in paediatric office settings. Paediatr Child Health (2008) 0.79
Evaluation of sample recovery efficiency for bacteriophage P22 on fomites. Appl Environ Microbiol (2012) 0.78
Comparison of methods of sampling for Toxocara species and fecal coliforms in an outdoor day care environment. Can J Infect Dis (1998) 0.76
Shelters for battered women and their children: an under-recognized source of communicable disease transmission. Am J Public Health (1987) 0.75
Handwashing to prevent diarrhea in day-care centers. Am J Epidemiol (1981) 3.75
Comparative adsorption of human enteroviruses, simian rotavirus, and selected bacteriophages to soils. Appl Environ Microbiol (1979) 3.68
Poliovirus concentration from tap water with electropositive adsorbent filters. Appl Environ Microbiol (1980) 3.27
Viral gastroenteritis. Prog Med Virol (1979) 3.14
Survival of poliovirus within organic solids during chlorination. Appl Environ Microbiol (1979) 2.02
Development of a method for detection of human rotavirus in water and sewage. Appl Environ Microbiol (1982) 2.01
Rearing regimen producing piglet diarrhea (rotavirus) and its relevance to acute infantile diarrhea. Science (1978) 1.43
The effects of relative humidity and temperature on the survival of human rotavirus in faeces. Arch Virol (1982) 1.43
Diarrhea in day care centers. Pediatr Infect Dis (1983) 1.29
Transmission of experimental rhinovirus infection by contaminated surfaces. Am J Epidemiol (1982) 1.18
Infectivity titers of enterovirus as found in human stools. J Med Virol (1980) 1.17
Human infective dose determinations for oral poliovirus type 1 vaccine in infants. J Clin Microbiol (1981) 1.03
Investigations on the circulation of enteroviruses in a children community. Virologie (1981) 0.88
COMPARISON OF THE ELUTION AND ADSORPTION OF PICORNAVIRUSES BY COTTON AND CALCIUM ALGINATE WOOL SWABS. Appl Microbiol (1965) 0.83
Pathogenesis of Escherichia coli diarrhea. N Engl J Med (1971) 10.36
Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea. Infect Immun (1978) 5.71
Typhoid fever: pathogenesis and immunologic control. N Engl J Med (1970) 4.95
Hemagglutination patterns of enterotoxigenic and enteropathogenic Escherichia coli determined with human, bovine, chicken, and guinea pig erythrocytes in the presence and absence of mannose. Infect Immun (1979) 4.60
Practice guidelines for the management of infectious diarrhea. Clin Infect Dis (2001) 4.49
Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966. Medicine (Baltimore) (1969) 4.20
Infantile diarrhea produced by heat-stable enterotoxigenic Escherichia coli. N Engl J Med (1976) 3.82
Rotavirus infections in infants as protection against subsequent infections. N Engl J Med (1996) 3.61
Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery. J Infect Dis (1973) 3.45
Inactivation of Norwalk virus in drinking water by chlorine. Appl Environ Microbiol (1985) 3.12
Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J Infect Dis (1974) 3.10
Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin Infect Dis (2001) 3.08
Diagnostic value of the Widal test in areas endemic for typhoid fever. Am J Trop Med Hyg (1978) 3.06
Patterns of loss of enterotoxigenicity by Escherichia coli isolated from adults with diarrhea: suggestive evidence for an interrelationship with serotype. Infect Immun (1977) 3.04
A newly recognized cause of travelers' diarrhea: enteroadherent Escherichia coli. J Infect Dis (1985) 2.94
Comparative susceptibility of latin american and united states students to enteric pathogens. N Engl J Med (1976) 2.94
The changing epidemiology of astrovirus-associated gastroenteritis: a review. Arch Virol Suppl (1996) 2.88
Differences in serological responses and excretion patterns of volunteers challenged with enterotoxigenic Escherichia coli with and without the colonization factor antigen. Infect Immun (1978) 2.78
Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect (2010) 2.77
Enterotoxigenic Escherichia-coli-associated diarrheal disease in Apache children. N Engl J Med (1975) 2.74
Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone. N Engl J Med (1982) 2.71
Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J Infect Dis (1999) 2.65
Role of Escherichia coli colonisation factor antigen in acute diarrhoea. Lancet (1978) 2.65
Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis (1990) 2.63
Typhoid fever: pathogenesis and immunologic control. 2. N Engl J Med (1970) 2.63
Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine. J Infect Dis (1977) 2.57
Adverse effect of lomotil therapy in shigellosis. JAMA (1973) 2.57
Virulence factors of enterotoxigenic Escherichia coli. J Infect Dis (1977) 2.45
Epidemiologic studies of an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections. Infect Control (1981) 2.43
Comparison of two assay methods for patterns of adherence to HEp-2 cells of Escherichia coli from patients with diarrhea. J Clin Microbiol (1990) 2.43
Expression, self-assembly, and antigenicity of a snow mountain agent-like calicivirus capsid protein. J Clin Microbiol (1995) 2.43
The isolation and characterization of a Norwalk virus-specific cDNA. J Clin Invest (1991) 2.42
Genetic diversity among sapoviruses. Arch Virol (2004) 2.33
Pathogenicity of enteroadherent Escherichia coli in adult volunteers. J Infect Dis (1986) 2.32
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect (2008) 2.30
Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection. J Infect Dis (1972) 2.29
Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole. N Engl J Med (1982) 2.27
Diarrhea caused by Shigella, rotavirus, and Giardia in day-care centers: prospective study. J Pediatr (1981) 2.21
Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens. Antimicrob Agents Chemother (1983) 2.20
Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth). JAMA (1980) 2.16
Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet (1998) 2.07
The response of man to virulent Shigella flexneri 2a. J Infect Dis (1969) 1.97
Limitations of using the plasmid pattern as an epidemiological tool for clinical isolates of Shigella sonnei. J Infect Dis (1987) 1.92
Ad libitum oral glucose-electrolyte therapy for acute diarrhea in Apache children. J Pediatr (1973) 1.92
Shiga-like cytotoxin production by enteropathogenic Escherichia coli serogroups. Infect Immun (1985) 1.87
Detection of enteric viruses in treated drinking water. Appl Environ Microbiol (1984) 1.87
Prospective study of enteropathogens in children with diarrhea in Houston and Mexico. J Pediatr (1978) 1.82
Occurrence of Giardia lamblia in children in day care centers. J Pediatr (1984) 1.82
Immunity in typhoid fever: evaluation of live streptomycin-dependent vaccine. Antimicrob Agents Chemother (Bethesda) (1970) 1.82
Treatment of falciparum malaria caused by strain resistant to quinine. JAMA (1970) 1.81
Acute infectious diarrhea among children in day care: epidemiology and control. Rev Infect Dis (1986) 1.81
Variability of human milk neutral oligosaccharides in a diverse population. J Pediatr Gastroenterol Nutr (2000) 1.81
Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans. Infect Immun (1985) 1.80
Effect of point-of-use disinfection, flocculation and combined flocculation-disinfection on drinking water quality in western Kenya. J Appl Microbiol (2004) 1.79
Effect of time and concentration upon interaction between gentamicin, tobramycin, Netilmicin, or amikacin and carbenicillin or ticarcillin. Antimicrob Agents Chemother (1979) 1.77
Clinical approach to infectious diarrheas. Medicine (Baltimore) (1973) 1.75
Antibodies to heat-labile Escherichia coli enterotoxin in Apaches in Whiteriver, Arizona. Infect Immun (1975) 1.75
The effect of diaper type and overclothing on fecal contamination in day-care centers. JAMA (1991) 1.74
Production of heat-stable, methanol-soluble enterotoxin by Yersinia enterocolitica. Infect Immun (1979) 1.73
Risk and aetiology of diarrhoea at various tourist destinations. Lancet (2000) 1.72
Anticytotoxin-neutralizing antibodies in immune globulin preparations: potential use in hemolytic-uremic syndrome. J Pediatr (1988) 1.68
Cryptosporidium, isospora and strongyloides in AIDS. Natl Med J India (1996) 1.67
The influence of protected water supplies on the spread of classical-Inaba and El Tor-Ogawa cholera in rural East Bengal. Lancet (1972) 1.66
Enteropathogenic Escherichia coli: lack of correlation of serotype with pathogenicity. J Infect Dis (1976) 1.65
Outbreaks of diarrhea associated with Clostridium difficile and its toxin in day-care centers: evidence of person-to-person spread. J Pediatr (1983) 1.63
The antibody response to 27-, 17-, and 15-kDa Cryptosporidium antigens following experimental infection in humans. J Infect Dis (1998) 1.61
Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum. Infect Immun (1998) 1.59
Child day care increases the risk of clinic visits for acute diarrhea and diarrhea due to rotavirus. Am J Epidemiol (1993) 1.58
A simple method for concentration of enteroviruses and rotaviruses from cell culture harvests using membrane filters. Intervirology (1978) 1.58
Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. Glycobiology (2001) 1.56
The relation between production of cytotoxin and clinical features in shigellosis. J Infect Dis (1986) 1.54
Enteropathogens associated with pediatric diarrhea in Mexico City. J Pediatr (1977) 1.53
Serum antibody as a marker of protection against natural rotavirus infection and disease. J Infect Dis (2000) 1.51
Clindamycin treatment of osteomyelitis and septic arthritis in children. Pediatrics (1975) 1.49
Fecal antibody responses to symptomatic and asymptomatic rotavirus infections. J Infect Dis (1993) 1.46
Fecal leukocytes in enteric infections. Am J Clin Pathol (1977) 1.44
Evaluation of new anti-infective drugs for the treatment of gastritis and peptic ulcer disease associated with infection by Helicobacter pylori. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 1.44
Emergence of resistant fecal Escherichia coli in travelers not taking prophylactic antimicrobial agents. Antimicrob Agents Chemother (1990) 1.43
Use of antimicrobial agents in animal feeds: implications for human health. Rev Infect Dis (1987) 1.43
Prevalence and genetic diversity of human caliciviruses (HuCVs) in Mexican children. J Med Virol (2000) 1.43
Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers. J Infect Dis (1996) 1.43
Transmission dynamics of enteric bacteria in day-care centers. Am J Epidemiol (1983) 1.43
Hydrops of the gallbladder associated with Epstein-Barr virus infection: a report of two cases and review of the literature. Pediatr Infect Dis J (1994) 1.42
Escherichia coli O114:nonmotile as a pathogen in an outbreak of severe diarrhea associated with a day care center. J Infect Dis (1989) 1.42
Reovirus-like agent and enterotoxigenic Escherichia coli infections in pediatric diarrhea in the Philippines. J Infect Dis (1978) 1.41
Oral fluid therapy of Apache children with acute infectious diarrhoea. Lancet (1972) 1.41
Molecular characterization of strains of enteroinvasive Escherichia coli O143, including isolates from a large outbreak in Houston, Texas. J Clin Microbiol (1992) 1.41